Dalata Hotel GP — Director's Dealing 2018

Nov 30, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1245J

Dalata Hotel Group PLC

30 November 2018

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Dalata Hotel Group plc announces today that Shane Casserly, the company's Head of Strategy & Development, has informed the Company that on the 30 November 2018 he purchased 5,300 ordinary shares of 0.01 cent each in the Company ("Ordinary Shares") at a price of €4.75

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Shane Casserly

2

Reason for the notification

a)

Position/status

Head of Strategy & Development

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dalata Hotel Group plc

b)

LEI

635400L2CWET7ONOBJ04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Dalata Hotel Group plc Ordinary Shares of €0.01 each

IE00BJMZDW83

b)

Nature of the transaction  

Purchase of Share

c)

Price(s) and volume(s)

Price(s)	Volume(s)
€4.75	5,300

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-11-30;

Place of the transaction

Dublin, Ireland

g)

Additional Information

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLLFSRLALIVIT